Showing results (1881-1890 of 1,967) with videos related to
Sort By:
Pageof 197
International Journal of Cancer|June 30, 2005
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCarey A Cullinane, Jan Lubinski, Susan L Neuhausen, et al.Brain : a Journal of Neurology|December 2, 2025
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.NPJ Dementia|June 22, 2026
Haplotype-resolved DNA methylation at the APOE locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease riskRylee M Genner, Melissa Meredith, Kensuke Daida, et al.Nature Genetics|October 30, 2024
Gene-based burden tests of rare germline variants identify six cancer susceptibility genesErna V Ivarsdottir, Julius Gudmundsson, Vinicius Tragante, et al.The Journal of Rheumatology|September 3, 2011
The OMERACT ultrasound task force--status and perspectivesEsperanza Naredo, Richard J Wakefield, Annamaria Iagnocco, et al.Breast Cancer Research : BCR|March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriersEitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.Frontiers in Medicine|January 30, 2023
The practice of genomic medicine: A delineation of the process and its governing principlesJulia Handra, Adrienne Elbert, Nour Gazzaz, et al.Lancet (London, England)|December 24, 2010
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trialGilles Salles, John Francis Seymour, Fritz Offner, et al.Journal of Surgical Oncology|August 5, 2014
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryArancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, et al.JAMA Oncology|February 29, 2024
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJan Lubinski, Joanne Kotsopoulos, Pal Moller, et al.Pageof 197